BC
IMCR icon

BIT Capital’s Immunocore IMCR Stock Holding History

BIT Capital’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,771
Closed -$64.3K – 125
2025
Q3 		$64.3K Sell
1,771
-405
-19% -$13.8K ﹤0.01% 98
2025
Q2 		$68.3K Sell
2,176
-38,611
-95% -$1.2M ﹤0.01% 81
2025
Q1 		$1.21M Sell
40,787
-27,053
-40% -$812K 0.1% 54
2024
Q4 		$2M Buy
67,840
+43,840
+183% +$1.39M 0.16% 56
2024
Q3 		$747K Sell
24,000
-8,749
-27% -$318K 0.07% 79
2024
Q2 		$1.11M Buy
32,749
+18,845
+136% +$961K 0.09% 74
2024
Q1 		$904K Buy
13,904
+9,901
+247% +$679K 0.07% 92
2023
Q4 		$273K Hold
4,003
– – 0.03% 67
2023
Q3 		$208K Hold
4,003
– – 0.02% 85
2023
Q2 		$240K Buy
4,003
+703
+21% +$40.1K 0.02% 107
2023
Q1 		$163K Buy
+3,300
New +$186K 0.02% 115

Other funds holding IMCR

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BIT Capital's IMCR Position: Q4 2025 in Review

BIT Capital sold out of Immunocore (IMCR) in Q4 2025, closing a stake of 1,771 shares — an estimated $64.3K sold.

BIT Capital first reported a position in IMCR in Q1 2023 and held it in 11 quarters. The position peaked at $2M in Q4 2024. 149 funds tracked by Wall St. Rank hold IMCR as of Q4 2025.

  • BIT Capital reported no remaining Immunocore position as of Q4 2025 after selling out during the quarter.
  • BIT Capital sold 1,771 Immunocore shares in Q4 2025, an estimated $64.3K.
  • BIT Capital first reported a position in Immunocore in Q1 2023 and held it in 11 quarters.
  • BIT Capital's Immunocore position peaked at $2M in Q4 2024.
  • 149 funds tracked by Wall St. Rank held Immunocore as of Q4 2025.

Based on BIT Capital's 13F filing for Q4 2025, filed 11 Feb 2026.